NKGEN BIOTECH INC -ON SEPT 23, GOT DEFICIENCY LETTER FROM NASDAQ ON CO'S FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD

Reuters · 09/27 20:03
NKGEN BIOTECH INC -ON SEPT 23, GOT DEFICIENCY LETTER FROM NASDAQ ON CO'S FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD